RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis
Min Yu(Howard Hughes Medical Institute), Daniel A. Haber(Howard Hughes Medical Institute), Fatih Ozsolak(Helicos Biosciences (United States)), Jordan C. Ciciliano(Georgia Institute of Technology), Daniel Winokur(Harvard University), Brian W. Brannigan(Harvard University), Malgorzata E. Smas(Harvard University), Ben S. Wittner(Broad Institute), Gianmarco Contino(University of Cambridge), Shyamala Maheswaran(Massachusetts General Hospital), David P. Ryan(East Carolina University), Brinda Alagesan(Cold Spring Harbor Laboratory), Anna J. Gilman(Harvard University), Shannon L. Stott(Shriners Hospitals for Children - Erie), Lecia V. Sequist(Harvard University), Mehmet Toner(Center for Cancer Research), Kristina Xega(Takeda (United States)), Nabeel Bardeesy(Broad Institute), Patrice M. Milos(Claritas Genomics (United States)), Suchismita Paul(Massachusetts General Hospital), Matthew Ulman(Harvard University), Sridhar Ramaswamy(Harvard University), David T. Ting(Massachusetts General Hospital)
Cited by 478
Related Papers
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
|Cell|2004|3.8k
Isolation of rare circulating tumour cells in cancer patients by microchip technology
|Nature|2007|3.5k
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations
|Journal of Clinical Oncology|2013|3.2k